Skip to main content
    P

    Purple Biotech (PPBT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.71
    +0.03 (+1.79%)

    Market Cap: $2.65M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Purple Biotech (PPBT) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Purple Biotech (PPBT) has a latest price of $1.71 on Nov 17, 2026, 80.8% below its 52-week high of $8.90. Its price fell 76.2% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 58.0%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $6,860.00 in Oct 2016 and its lowest $1.17 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart PPBT with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PPBT.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 7.5%, and over 6 months it fell 51.3%. The month-end price fell 99.6% over the 3 years through Oct 2026, a compound annual decline of 83.7%.

    PeriodChange
    1 month+58.3%
    3 months+7.5%
    6 months-51.3%
    12 months-76.2%
    12 months, with dividends-76.2%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-99.6%-83.7%
    5 years-99.9%-73.3%
    10 years-100.0%-58.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 18.2%, and its weakest was 2025, when it fell 86.0%.

    YearCloseChange
    2026 through Oct 2026$1.17-82.2%
    2025$6.58-86.0%
    2024$46.90-69.9%
    2023$156.00-43.5%
    2022$276.00-64.5%
    2021$778.00+2.1%
    2020$762.00-51.2%
    2019$1,560.00+18.2%
    2018$1,320.00-71.1%
    2017$4,560.00-26.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 23.3% above its 50-day average of $1.39 and 37.2% below its 200-day average of $2.72.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.71
    52-week high$8.90-80.8%
    52-week low$0.91+87.9%
    50-day average$1.39+23.3%
    200-day average$2.72-37.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 99.6%.

    MeasureValue
    1-year beta0.08
    Largest fall, 1 year-89.4%
    Largest fall, 3 years-99.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About PPBT

    What is PPBT's 1-year price change?

    Purple Biotech's price fell 76.2% over the past 12 months. With dividends included, the 12-month total return was -76.2%.

    What is PPBT's 5-year price change?

    Purple Biotech's month-end price fell 99.9% over the 5 years through Oct 2026, a compound annual decline of 73.3%. These figures leave out dividends.

    What is PPBT's 52-week high and low?

    Purple Biotech's 52-week high is $8.90 and its 52-week low is $0.91. Its latest price of $1.71 on Nov 17, 2026 is 80.8% below the high.

    What is PPBT's beta?

    Purple Biotech's 1-year beta against the S&P 500 is 0.08, so its price has shown little link to the market's moves over the past year. Its largest fall from a peak over the past year was 89.4%.

    Is the PPBT chart free?

    Yes. Advanced Charting for PPBT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.